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Vascular disease as a cause of death 
in patients with severe disability due 
to osteoarthritis and rheumatoid arthritis
Ann Marie Smith1*, Liz Lingard2, Peta Heslop3, Janine Gray4 and David J Walker1
Abstract 
Objectives: The mechanism of the increased risk of cardiovascular disease in rheumatoid arthritis (RA) remains 
uncertain. We had the opportunity to compare the causes and ages of death in a population of osteoarthritis (OA) 
and RA patients who had had similar lower limb disability.
Methods: Death certificates were sought for a population of OA and RA patients who had had knee joint replace-
ments performed by a single orthopaedic surgeon over a 10 year period with a minimum follow up period of 
18 years. Primary cause of death was assigned by a blinded clinician and compared between the populations. Com-
peting risk analysis was used to compare RA and OA populations for cardiovascular deaths.
Results: The total population was 607 (294 OA; 313 RA). 85% (249) of the OA and 79% (246) of the RA patients had 
deceased at the time of study in 2008. 85% of the death certificates were found. The RA patients were operated an 
average of 7.5 years younger and also died 7.5 years younger. The causes of death were similar in the two popula-
tions. The ages at death were consistently and similarly older for the OA group for all causes of death. There was a 9% 
increased risk of cardiovascular death in the RA group but this was not statistically different from the OA group.
Conclusions: OA and RA patients, controlled for lower limb disability, have similar causes of death including cardio-
vascular disease. However, the RA patients died significantly younger. Cause of death is likely to be related to things 
that OA and RA share, such as disability and some treatments e.g. NSAIDs, whereas age at death relates to differences, 
such as age of onset and inflammation.
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Background
The association of rheumatoid arthritis (RA) with 
increased vascular disease is well established (Kitas 
et  al. 2001; Sattar et  al. 2003). The mechanism of this 
risk is less certain with studies of traditional factors 
showing conflicting results (McEntegart et  al. 2001; del 
Rincon et  al. 2001; Maradit-Kremers et  al. 2005). There 
is stronger association with higher disease activity and 
disability, and extra-articular disease (Peltomaa et  al. 
2002) but these are interrelated. In a recent study from 
our area, cardiovascular disease was found to be a greater 
cause of death in longstanding RA patients when com-
pared to their siblings, but not when compared to simi-
larly longstanding osteoarthritis (OA) patients (Kumar 
et al. 2007). This suggested that the risk factors for vas-
cular disease were shared by OA and RA rather than 
being familial. We were presented with another inter-
esting population in which to explore vascular risk in 
OA and RA, when a 15 year follow up study of a prolific 
surgeon’s experience of knee replacements revealed that 
four-fifths were deceased (Loughead et al. 2008). Unlike 
patients who come to surgery today, the population was 
of almost equal numbers diagnosed with OA and RA, 
and all patients crossed one surgeon’s threshold for sur-
gery and were likely to be similarly disabled at the time 
Open Access
*Correspondence:  ann-marie.smith@ncl.ac.uk 
1 Rheumatology Department, Room 22, Musculoskeletal Unit, The 
Newcastle upon Tyne Hospitals NHS Foundation Trust, The Freeman 
Hospital, Newcastle upon Tyne NE7 7DN, UK
Full list of author information is available at the end of the article
Page 2 of 4Smith et al. SpringerPlus  (2015) 4:328 
of the surgery. We were interested to investigate the ages 
and causes of death in this population.
Methods
The population had recently been studied for outcome 
from the surgery (Loughead et  al. 2008). The original 
population was of 619 patients identified from theatre 
records having had total knee replacements performed 
by one surgeon between 1980 and 1990. Records of 
the patients were available and were demographically 
updated from the Newcastle Hospitals Patient Admin-
istrative System and then we used The National Health 
Service Strategic Tracing Service to check if patients were 
still alive, and identify patients who were deceased and 
the date of death. The patient data was further refined, 
identifying the National Health Service number on all 
patients and the most recent known address. Informa-
tion on the cause of death was requested from National 
Health Service Medical Research at The Information 
Centre for Health and Social Care who provided death 
certificates in December 2008.
The way in which death certificates were completed 
was variable with different words being used in different 
parts of the certificate. Similarly, descriptions of associ-
ated conditions in “Methods” may have been relevant 
underlying the cause of death in “Background”. It was 
therefore necessary for the certificates to be scrutinised 
by a clinician to allocate a suitable category for cause of 
death. The clinician was blind to the diagnosis of arthritis 
unless it appeared on the certificate. Deaths were allo-
cated as primarily cardiovascular, cerebrovascular or 
peripheral vascular, or were allocated to another cause of 
death. Other causes are categorised as in Table 1. A file of 
what was written on the certificates and how we catego-
rised them is available.
Analysis
Ages at death were compared using the log-rank test, 
censoring age of patients at the study cut-off date of 1st 
August 2008. Competing risks analysis (Fine and Gray 
1999) was used to compare the RA and OA groups 
in terms of vascular death; all deaths of other causes 
were classified as a competing risk and the analysis was 
adjusted for age and sex. STATA v11 was used for all 
analysis.
Results
The total population was of 607: 294 OA and 313 RA. 
249 of the OA (85%) and 246 of the RA (79%) subjects 
were deceased. Females accounted for 65% of the OA and 
80% of the RA patients. 11% of the OA and 24% of the RA 
had bilateral knee replacements. Death certificates were 
found for 86% (214) of the OA and 84% (207) of the RA 
patients. RA appeared on the death certificates of 45 peo-
ple (22%). For OA it was only 2 (1%).
The ages at operation and death for both popula-
tions were different. The OA patients had a mean age 
at first surgery of 70.79 compared to the RA patients 
Table 1 The number of people dying of the different causes
Number (%).
Cause of death OA
n = 249
RA
n = 246
Number of subjects by diagnosis Mean age at death Number of subjects by diagnosis Mean age at death
Number (%) Years (range) Number (%) Years (range)
Cardiovascular 64 (25.70%) 81.14 (58–95) 65 (26.42%) 75.23 (61–95)
Cerebrovascular 21 (8.43%) 84.57 (69–93) 20 (8.13%) 77.96 (67–91)
Peripheral vascular 5 (2.01%) 77.64 (73–81) 10 (4.07%) 74.65 (48–87)
Rheumatoid arthritis 0 (0%) 0 4 (1.63%) 79.36 (73–83)
Septic 61 (24.50%) 84.22 (62–100) 62 (25.20%) 74.98 (55–92)
Cancer 27 (10.84%) 81.14 (66–99) 9 (3.66%) 75.89 (56–85)
Accident 2 (0.80%) 81.97 (76–88) 2 (0.81%) 76.05 (72–81)
Renal 6 (2.41%) 85.47 (71–96) 7 (2.85%) 75.06 (58–83)
Chest 1 (0.40%) 67.49 (0) 9 (3.66%) 74.21 (65–83)
Old age 11 (4.42%) 88.23 (80–94) 5 (2.03%) 82.00 (76–90)
Neurological 7 (2.81%) 88.67 (82–96) 2 (0.81%) 81.11 (77–86)
Gastrointestinal and liver 3 (1.21%) 80.88 (76–89) 12 (4.88%) 69.99 (49–80)
Pulmonary embolism 6 (2.41%) 83.23 (76–90) 1 (0.41) 63.07 (0)
No diagnosis 35 (14.06%) 75.49 (53–90) 38 (15.45%) 70.04 (45–82)
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at 63.58 years (p < 0.001, t test). The ages at death were 
similarly different with the OA patients dying at a median 
age of 81.97  years and the RA at 74.5  years (P  <  0.001, 
log-rank test). OA patients came to surgery an average 
of 7  years older and died at a similarly older age. The 
patients who were identified alive (109 patients, 3 sta-
tus not known) at the censored data point of 1st August 
2008 had a median age for OA of 88.87 years and for RA 
median age of 76.56.
The causes of death for the two populations are shown 
in Table 1. 30% of the OA population and 28% of the RA 
population had died of vascular causes. Of the other 
causes only cancer (more common in the older OA pop-
ulation) looked different. Vascular causes of death are 
similar in OA and RA patients controlled for lower limb 
disability.
The ages at death for the different causes of death are 
also shown in Table  1. As can be seen the OA patients 
died at an older age than the RA patients for each cause 
of death. The increased age at death was consistent over 
all causes.
The competing risk analysis showed that the RA sub-
jects were at a 9% greater risk of a vascular death com-
pared to the OA subjects (OR 1.09 95% CI 0.6–1.5), 
adjusted for age and sex. This was not significantly dif-
ferent. The cumulative incidence of death from a vascu-
lar cause over time starting with the date of operation are 
shown in Figure 1 for both RA and OA subjects and can 
be seen to be similar.
Discussion
This population is an interesting natural experiment 
where substantial and almost equal numbers of OA and 
RA patients have been operated on and followed up by a 
single surgeon. All of the patients will have crossed this 
surgeon’s threshold for surgery which would have been 
based on the amount of pain and disability that the knee 
was causing at the time the decision was made. It is likely 
that a similar threshold would have been used for both 
populations although the upper limb disability is likely 
to have been greater in the RA group. The progression 
of the disability in the RA group is likely to have been 
quicker meaning that the area under the time/disability 
curve may have been smaller for the RA patients. Never-
theless, these patients are reasonably controlled between 
populations for their severe disability, allowing us to look 
at other factors in relation to the cause of death. No sig-
nificant differences in terms of death from a vascular 
cause were found between the OA and RA samples, indi-
cating that OA patients may be at a similarly high risk for 
cardiovascular death as RA patients, as long as they are 
similarly disabled.
In contrast there was a difference in age at death 
between the populations. OA is a condition that tends 
to start later in life than RA, and becomes progressively 
more common with age. RA on the other hand more 
usually comes on in middle age. Both are likely to cause 
increasing disability with increasing duration. If physi-
cal disability is a major factor in cardiovascular disease 
in these populations then it is likely to be a risk that 
increases with increased disability and with duration of 
that disability and association with disease severity has 
been shown (Peltomaa et  al. 2002). The later onset of 
disease and disability in the OA population leading to 
increased vascular disease at a later age than RA would be 
expected and is consistent with this data. The increased 
cardiovascular disease in RA has been associated with 
more multisystem involvement and higher inflammation 
as measured by ESR and CRP (Wallberg-Jonsson et  al. 
2000). This increased inflammation, however, also marks 
for more severe disease and so these patients are likely to 
be more disabled as well.
The observation that the OA and RA patients died of 
similar causes suggests that the risk is related to things 
that OA and RA share. As well as disability/decondition-
ing this would include some treatments such as non-ste-
roidal anti-inflammatory drugs (NSAIDs) and analgesics 
which both populations take. Unfortunately we do not 
have detailed information on the drug usage of these 
patients. They are all likely to have been tried on NSAIDs 
and analgesics prior to consideration of surgery, but it 
is likely to be the dose and duration of treatment that is 
important as shown in the coxib studies (Hippisley-Cox 
and Coupland 2005).
There is some support for exercise decreasing the car-
diovascular risk in RA from a study looking at an educa-
tion programme where exercise was encouraged (Holly 
et al. 2013).
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Figure 1 Competing risk analysis for death over time starting with 
the date of operation. Probability of dying a vascular death adjusted 
for age, disparity and competing risks.
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In a study of cause of death in RA from a similar time 
period in Sweden (Kapetanovic et  al. 2011), cardiovas-
cular disease accounted for 46% compared to 20% in our 
population. A much bigger difference was seen for malig-
nancy with 29% in their population and only 4% in our 
population. However, infection was more common in our 
population (25 versus 13%). Interestingly RA appeared 
on the death certificate in similar proportion of patients 
(23% in Sweden and 18% UK). OA appeared on the death 
certificates in less than 1% of our population.
Limitations
There is huge variability in the words used on death cer-
tificates and in order to categorise them, arbitrary and 
convenient decisions have been made. A file is available. 
This is a retrospective observational study and so has 
limitations. We are limited by the data that was collected 
at the time and so unable to look in detail at traditional 
risk factors for cardio-vascular disease. We do not have 
detailed breakdown of drug therapies or other measures 
of disability. As discussed above there will be some dif-
ferences in the development and effects of the disease 
between the diagnoses and the surgeon may have had 
slightly different criteria for surgery in OA and RA. The 
RA population was younger and this may have deterred 
the surgeon who would be concerned about the lifes-
pan of the prosthesis. However, there would also be an 
inevitability about the future need for surgery in a patient 
with destructive RA that might have made the decision 
to operate more likely. Overall it is likely that these pop-
ulations had similar lower limb disability at the time of 
surgery.
Conclusion
In conclusion, the rate of vascular cause of death was 
similar between the two populations, controlled for lower 
limb disability, suggesting similarities between OA and 
RA that gives rise to this effect. This could be the physical 
disability, which was severe in both of these groups, or an 
effect of common treatments such as NSAIDs or anal-
gesics. The age at death was significantly different and is 
therefore likely to relate to differences between OA and 
RA. These would include age of onset and inflammation.
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